Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11)
BNXTFCurrent price
0.18 USD
0 USD (0.00%)
Last closed
0.24 CAD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
CN
Capitalization
29 408 005 CAD
Yield for 12 month
-26.47 %
1Y
3Y
5Y
10Y
15Y
BNXTF
BioNxt Solutions Inc. engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains. In addition, the company offers psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. Further, it provides analytical testing and consulting services. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. The company was incorporated in 2017 and is headquartered in Vancouver, Canada. Address: 1820 Fir Street, Vancouver, BC, Canada, V6J 3B1
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures BNXTF
1 year
3 years
5 years
10 years
EBITDA
-5 007 068 CAD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-228.25 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
–
Revenue TTM
30 661 CAD
Book Value
-0.054 CAD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-99.3 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.06 CAD
Diluted Eps TTM
-0.06 CAD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BNXTF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BNXTF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation BNXTF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1124.0893
Price Sales TTM
959.1324
Enterprise Value EBITDA
-5.5318
Price Book MRQ
20.6812
Financials BNXTF
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BNXTF
For 52 weeks
0.17 CAD
0.75 CAD
50 Day MA
0.23 CAD
Shares Short Prior Month
1 679
200 Day MA
0.38 CAD
Short Ratio
–
Shares Short
6 384
Short Percent
–
BeatStart